Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOW DOse vs standard dose and administration TIme in near-infrared fluorescence cholangiography during laparoscopic cholecystectomy
2025-522535-33-00Phase 4Authorised
- Sponsor
- Fundación de Investigación Biomédica de Salamanca
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of indocyanine green in cholelithiasis, gallbladder polyp, acute calculous cholecystitis and 4 more (2 arms), sponsored by Fundación de Investigación Biomédica de Salamanca. Planned start Aug 2025; status: authorised.
02
Drugs
indocyanine green
03
Conditions
cholelithiasisgallbladder polypacute calculous cholecystitisacalculous cholecystitis (AAC)choledocholithiasis
Beyond the preview
Go deeper on 2025-522535-33-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522535-33-00.